Showing 1 posts of 1 posts found.
Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement